Big money in cancer diagnostics...might be block buster product.
Weil Cornell is our lung PanC partner and rumored to announce final product at up coming cancer presentation. As for our breast PanC partner...
"HESC's can' be manipulated?"....More false information. From what I hear spine trials, AMD trials all going well, even cancer diagnostic vaccine using dendritic hESC progenitors good so far.
More recent news(today from Cambridge) qualifying the importance of 'embryonic pluripotent' stem cells:
Ah yes 'progenitor' cells, I do believe BTX has patented more then 200 lines of these progenitors covering just about every part of the body.
-Pan-C-DX breast, lung, bladder cancer diagnostic products
-Robert Lanza's next job
-BTX's next acquisition
-Stem cell sector surviving companies
-Leading stem cell companies
-Stem cell transplants using growth factors